<DOC>
	<DOCNO>NCT00420004</DOCNO>
	<brief_summary>This study ass safety effectiveness LY2216684 compare placebo treat adult major depressive disorder .</brief_summary>
	<brief_title>A Study Patients With Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Phenylethyl Alcohol</mesh_term>
	<criteria>Meet criterion major depressive disorder ( MDD ) without psychotic feature . Have education level degree understand patient communicate site study personnel . Judged reliable agree keep appointment clinic visit , test , procedure , include venipuncture , examination require protocol . Have additional , ongoing psychiatric condition major depression dysthymia consider primary diagnosis within 6 month Visit 1 . Have lifetime history Bipolar I II Disorder , psychotic disorder , factitious disorder . Are judged high risk imminently harm others . Have serious medical illness , include cardiovascular , hepatic , respiratory , hematologic , endocrinologic , neurologic disease , clinically significant laboratory ECG abnormality . Clinically significant lab abnormality , judgment investigator , indicate serious medical problem require intervention . Have diagnose medical condition could exacerbate treatment LY2216684 include hypertension , increased heart rate , arrhythmia , heart disease , narrow angle glaucoma , urinary hesitancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>